02Jul/13

Piper Jaffray Reiterates “Neutral” Rating for Biogen Idec (BIIB) – Watch List News (press release)

Piper Jaffray Reiterates “Neutral” Rating for Biogen Idec (BIIB)
Watch List News (press release)
in particular unpublished estimates) now fully reflect Tecfidera’s strong launch, in our view, and upside in BIIB shares will likely require pipeline success, which is not expected until 2014 data readouts from anti-LINGO Phase II (optic neuritis

02Jul/13

Few Japanese willing to state desire regarding organ donation – The Japan Times


BBC News

Few Japanese willing to state desire regarding organ donation
The Japan Times
The Japan Organ Transport Network said Tuesday 15.7 percent of people recently surveyed said they have declared their will on whether or not they wish to donate their organs after brain death or cardiac death. The figure is higher than the 11.1 percent
The most useful thing you’ll do today?BBC News
Now, donor labels on driving licencesTimes of India
Reducing Bureaucracy, Saving LivesEconomic and Political Weekly

all 110 news articles »

02Jul/13

JIM – Un nouvel anticorps monoclonal pour le traitement de la sclérose en plaques – Journal International de Médecine (Inscription)

JIM – Un nouvel anticorps monoclonal pour le traitement de la sclérose en plaques
Journal International de Médecine (Inscription)
Ainsi, le daclizumab est un anticorps monoclonal humanisé spécifique du récepteur CD25 diminuant l’activation immunitaire via l’interleukine 2. Plus de 600 patients ont été inclus dans l’étude SELECT, randomisée, en double aveugle et contre placebo